After administration of the IL-17A inhibitor SECU, the wound length of the T2DM mice in the SECU group was larger than that of the FMT group (**P < 0.05, Fig. 1F), indicating that FMT can facilitate wound repair in T2DM mice. This evidence concerns the gene IL17A and type 2 diabetes mellitus.